About Betta Pharmaceuticals Company

Established in 2003, the company is a high-tech pharmaceutical enterprise founded by a team of high-level talents returning from overseas, integrating R&D, production, marketing and sales with independent intellectual property as the core, research and development of innovative drugs. On November 7, 2016, Betta Pharmaceuticals was listed on the Shenzhen Stock Exchange. The company is a national high-tech enterprise founded by Dr. Overseas Returning, with research and development of innovative drugs with independent intellectual property as the core, integrating R&D, production and marketing. The company's main products, Kaimena, Bemena, and Vomena, are chemical pharmaceuticals. Corporate honors: Chairman Ding Lieming won the title of “Outstanding Person in the Overseas Chinese Community”; Gao Yaqin, the company's senior QC commissioner, won the National May 1st Labor Medal; Chairman Ding Lieming won the Zhejiang Science and Technology Significant Contribution Award; Beida Pharmaceutical won the first “Four Strong Provinces” leading enterprise in Zhejiang; Dr. Ding Lieming won the first “Global Zhejiang Gold Award”, etc.